These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8037885)

  • 1. Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats.
    Kehoe P; Boylan CB
    Behav Neurosci; 1994 Apr; 108(2):418-23. PubMed ID: 8037885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U50,488 increases ultrasonic vocalizations in 3-, 10-, and 18-day-old rat pups in isolation and the home cage.
    Carden SE; Davachi L; Hofer MA
    Dev Psychobiol; 1994 Jan; 27(1):65-83. PubMed ID: 8112489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonic vocalizations are elicited from rat pups in the home cage by pentylenetetrazol and U50,488, but not naltrexone.
    Carden SE; Bortot AT; Hofer MA
    Behav Neurosci; 1993 Oct; 107(5):851-9. PubMed ID: 8280394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
    Nazarian A; Krall CM; Osburn JR; McDougall SA
    Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ
    Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioid effects on fetal behavior: central administration of U50,488.
    Petrov ES; Varlinskaya EI; Robinson SR; Smotherman WP; de Costa BR; Rice KC
    Physiol Behav; 1994 Jul; 56(1):175-82. PubMed ID: 8084898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
    Bianchi M; Panerai AE
    Pharmacol Biochem Behav; 1993 Sep; 46(1):145-8. PubMed ID: 8255904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.
    Jackson HC; Kitchen I
    Psychopharmacology (Berl); 1989; 97(3):404-9. PubMed ID: 2541460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of specific opioid receptor agonists on rat pup isolation calls.
    Carden SE; Barr GA; Hofer MA
    Brain Res Dev Brain Res; 1991 Sep; 62(1):17-22. PubMed ID: 1662121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
    Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
    Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC; West TE; Wise RA
    Brain Res; 1991 Jun; 550(2):205-12. PubMed ID: 1653084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptor modulation of nicotine-induced behaviour.
    Hahn B; Stolerman IP; Shoaib M
    Neuropharmacology; 2000 Oct; 39(13):2848-55. PubMed ID: 11044755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
    Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
    Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)-lobeline in the rat brainstem.
    Hamann SR; Martin WR
    Pharmacol Biochem Behav; 1994 Jan; 47(1):197-201. PubMed ID: 8115422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup.
    Barr GA; Wang S; Carden S
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):422-8. PubMed ID: 7862854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCB, a novel specific kappa opioid agonist, which discriminates between opioid and sigma 1 recognition sites.
    Ronsisvalle G; Prezzavento O; Pasquinucci L; Marrazzo A; Vittorio F; Gomez-Vidal JA; Carboni L; Spampinato S
    Life Sci; 1995; 57(16):1487-95. PubMed ID: 7564893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS
    Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.